![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
1. 905818-69-1
2. Aplenzin
3. Bupropion Hbr
4. Bupropion Hydrobromide [usan]
5. Bupropion (hydrobromide)
6. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one Hydrobromide
7. Bvf-033
8. E70g3g5863
9. Bupropion Hydrobromide (usan)
10. Aplenzin Er
11. Unii-e70g3g5863
12. Aplenzin (tn)
13. Schembl636116
14. Chembl1201735
15. Dtxsid20920317
16. Bupropion Hydrobromide [mi]
17. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,hydrobromide
18. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrobromide
19. Bupropion Hydrobromide [vandf]
20. Akos015917698
21. Bupropion Hydrobromide [mart.]
22. Bupropion Hydrobromide [usp-rs]
23. Bupropion Hydrobromide [who-dd]
24. Bupropion Hydrobromide [orange Book]
25. D07938
26. Q27276951
27. (2rs)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)propan-1-one Hbr
28. (2rs)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)propan-1-one Hydrobromide
29. 1-propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, Hbr (1:1)
30. 1-propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, Hydrobromide (1:1)
31. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one--hydrogen Bromide (1/1)
Molecular Weight | 320.65 g/mol |
---|---|
Molecular Formula | C13H19BrClNO |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 4 |
Exact Mass | 319.03385 g/mol |
Monoisotopic Mass | 319.03385 g/mol |
Topological Polar Surface Area | 29.1 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 247 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Aplenzin |
Active Ingredient | Bupropion hydrobromide |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 348mg; 522mg; 174mg |
Market Status | Prescription |
Company | Valeant Bermuda |
2 of 4 | |
---|---|
Drug Name | Bupropion hydrobromide |
PubMed Health | Bupropion (By mouth) |
Drug Classes | Antidepressant, Smoking Cessation Agent |
Active Ingredient | Bupropion hydrobromide |
Dosage Form | Tablet, extended release |
Route | oral |
Strength | 522mg; 174mg |
Market Status | Tentative Approval |
Company | Watson Labs |
3 of 4 | |
---|---|
Drug Name | Aplenzin |
Active Ingredient | Bupropion hydrobromide |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 348mg; 522mg; 174mg |
Market Status | Prescription |
Company | Valeant Bermuda |
4 of 4 | |
---|---|
Drug Name | Bupropion hydrobromide |
PubMed Health | Bupropion (By mouth) |
Drug Classes | Antidepressant, Smoking Cessation Agent |
Active Ingredient | Bupropion hydrobromide |
Dosage Form | Tablet, extended release |
Route | oral |
Strength | 522mg; 174mg |
Market Status | Tentative Approval |
Company | Watson Labs |